輸入代號或公司名稱後按 Enter
4174

浩鼎

+0.65 (+2.50%)最後更新 2026-09-16
台灣 · 上櫃 · 生技醫療業
26.65239成交張數本益比2.30股價淨值比0.00%殖利率2026-09-16資料日期

綜合損益表公開資訊觀測站申報原值 · 年度(第 4 季累計) · 每一格 = 該科目 ÷ 營業收入

營業收入202559年增 -6.5%
毛利率2025-132.4%最新一期
營業利益率2025-3702.6%最新一期
每股盈餘2025-15.61
會計項目走勢2016201720182019202020212022202320242025
營業收入合計100.0%100.0%100.0%100.0%100.0%100.0%100.0%100.0%100.0%100.0%
營業成本合計0.0%0.0%39.6%0.0%4.6%236.3%952.1%276.9%221.7%232.4%
營業毛利(毛損)100.0%100.0%60.4%100.0%95.4%-136.3%-852.1%-176.9%-121.7%-132.4%
營業毛利(毛損)淨額100.0%100.0%60.4%100.0%95.4%-136.3%-852.1%-176.9%-121.7%-132.4%
管理費用373.7%90768.4%2313.9%30681.0%206.1%1282.9%6575.3%768.4%521.4%617.9%
研究發展費用930.0%225725.8%8449.5%135802.2%929.7%7722.1%37632.3%4084.4%3140.6%2952.3%
營業費用合計1303.7%316494.1%10763.4%166483.1%1135.9%9005.0%44207.6%4852.8%3662.0%3570.2%
營業利益(損失)-1203.7%-316394.1%-10703.1%-166383.1%-1040.5%-9141.3%-45059.7%-5029.7%-3783.7%-3702.6%
利息收入30.8%34.4%1059.9%223.7%63.9%50.9%
其他收入91.4%15398.9%681.7%10913.0%5.9%47.1%87.1%23.4%20.9%81.9%
其他利益及損失淨額-85.9%-65030.1%619.4%-9951.0%-53.5%-201.1%3303.4%2125.4%105.2%79.6%
財務成本淨額0.2%319.7%12.5%310.6%3.0%20.2%84.7%19.1%17.0%22.4%
採用權益法認列之關聯企業及合資損益之份額淨額-393.7%-372.0%-344.8%
營業外收入及支出合計5.2%-49950.8%1288.6%651.4%-19.7%-139.8%4365.7%1959.7%-198.9%-154.8%
稅前淨利(淨損)-1198.4%-366344.9%-9414.5%-165731.8%-1060.2%-9281.1%-40694.0%-3070.0%-3982.6%-3857.4%
所得稅費用(利益)合計2.7%526.3%-47.3%-641.2%-2.7%-129.8%-377.2%-23.1%-5.7%-4.7%
繼續營業單位本期淨利(淨損)-1201.2%-366871.3%-9367.2%-165090.6%-1057.5%-9151.3%-40316.8%-3046.9%-3976.9%-3852.8%
本期淨利(淨損)-1201.2%-366871.3%-9367.2%-165090.6%-1057.5%-9151.3%-40316.8%-3046.9%-3976.9%-3852.8%
透過其他綜合損益按公允價值衡量之權益工具投資未實現評價損益-20.3%99.1%-0.2%5.7%-8.1%4.6%-2.6%-2.7%
不重分類至損益之項目:99.1%-0.2%5.7%-8.1%4.6%-2.6%-2.7%
國外營運機構財務報表換算之兌換差額-1.2%-967.6%3.1%-210.9%4.2%-46.9%180.7%-1.3%7.4%-5.4%
採用權益法認列之關聯企業及合資之其他綜合損益之份額-可能重分類至損益之項目-0.4%1.0%
後續可能重分類至損益之項目:-210.9%4.2%-46.9%180.7%-1.3%7.0%-4.4%
其他綜合損益(淨額)-1.2%-5494.4%-17.1%-111.8%4.0%-41.2%172.6%3.2%4.5%-7.1%
本期綜合損益總額-1202.4%-372365.7%-9384.4%-165202.4%-1053.5%-9192.6%-40144.2%-3043.7%-3972.4%-3859.8%
母公司業主(淨利∕損)-1201.2%-366871.3%-9162.9%-161356.2%-978.0%-8154.1%-34258.5%-2518.7%-3685.5%-3504.6%
非控制權益(淨利∕損)-204.3%-3734.4%-23.0%-997.2%-6058.3%-528.3%-291.4%-348.2%
母公司業主(綜合損益)-1202.4%-372365.7%-9179.3%-161468.0%-974.1%-8195.3%-34088.9%-2515.3%-3679.9%-3511.7%
非控制權益(綜合損益)-205.1%-3734.4%-23.0%-997.2%-6055.3%-528.3%-292.5%-348.2%
繼續營業單位淨利(淨損)-0.0%-2.1%-0.1%-0.9%-0.0%-0.0%-0.2%-0.0%-0.0%-0.0%
基本每股盈餘-7.0%-2143.6%-52.9%-889.9%-5.2%-41.0%-154.3%-11.0%-15.8%-26.6%
共同控制下前手權益(淨利∕損)-56.5%0.0%
共同控制下前手權益(綜合損益)-56.5%0.0%
備供出售金融資產未實現評價損益-4526.9%0.0%

金額為公司申報原值除以一千(百萬元,四捨五入),每股金額為元。年度為第 4 季的年初至今累計數。走勢條是歷史各期的相對大小,藍為正、綠為負。年增以去年同期為基期,基期非正數或變動超過十倍時不列。 權益變動表在申報資料分頁。